FQ
ENZN

First Quadrant’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

First Quadrant’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-81,700
Closed -$88K – 837
2014
Q3 		$88K Hold
81,700
– – ﹤0.01% 632
2014
Q2 		$85K Sell
81,700
-100
-0.1% -$95 ﹤0.01% 652
2014
Q1 		$84K Buy
81,800
+35,300
+76% +$36.5K ﹤0.01% 601
2013
Q4 		$54K Sell
46,500
-1,400
-3% -$2.16K ﹤0.01% 677
2013
Q3 		$80K Sell
47,900
-11,700
-20% -$21.6K ﹤0.01% 630
2013
Q2 		$119K Buy
+59,600
New +$174K ﹤0.01% 580

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Quadrant's ENZN Position: Q4 2014 in Review

First Quadrant sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2014, closing a stake of 81,700 shares — an estimated $88K sold.

First Quadrant first reported a position in ENZN in Q2 2013 and held it in 6 quarters. The position peaked at $119K in Q2 2013. 57 funds tracked by Wall St. Rank hold ENZN as of Q4 2014.

  • First Quadrant reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • First Quadrant sold 81,700 ENZON PHARMACEUTICALS INC shares in Q4 2014, an estimated $88K.
  • First Quadrant first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • First Quadrant's ENZON PHARMACEUTICALS INC position peaked at $119K in Q2 2013.
  • 57 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2014.

Based on First Quadrant's 13F filing for Q4 2014, filed 27 Jan 2015.